Perrigo Company

Perrigo Company
Name	Perrigo Company
Type	Public
Industry	Pharmaceuticals
Founded	1887
Founder	Luther Perrigo
Headquarters	Allegan, Michigan, United States
Key people	Murray S. Kessler, John H. Hendrickson
Products	Over-the-counter drugs, generic pharmaceuticals, infant formula
Revenue	(see Financial Performance and Operations)
Website	(official website)

Perrigo Company

Perrigo Company is a U.S.-founded manufacturer of over-the-counter drugs and private label pharmaceuticals with global operations headquartered in Allegan, Michigan. The company is known for supplying retailers, supermarkets, and Walmart with store-brand health products, and has engaged in major corporate actions involving cross-border tax strategies, acquisitions, and divestitures. Perrigo has been involved with notable industry players such as Teva Pharmaceutical Industries, Mylan, and Nestlé through competitive, regulatory, and transactional interactions.

History

Perrigo began in 1887 when Luther Perrigo opened a retail store in Edwardsburg, Michigan and evolved into a manufacturer of store-brand pharmaceuticals during the 20th century, expanding through acquisitions and organic growth alongside peers like Johnson & Johnson and Procter & Gamble. In the 1990s and 2000s Perrigo pursued consolidation, acquiring companies such as Omega Pharma competitors and aligning with retailers similar to Walgreens Boots Alliance and CVS Health to supply private-label products. In 2013 Perrigo announced a proposed tax inversion merger that drew comparisons to transactions by Medtronic and Pfizer and led to significant public scrutiny and regulatory attention from U.S. Treasury Department and members of United States Congress. Subsequent years saw further strategic moves, including acquisitions of over-the-counter businesses and divestitures to streamline portfolios, echoing patterns seen with GlaxoSmithKline and Sanofi spin-offs.

Corporate Structure and Governance

Perrigo is incorporated with a board of directors and executive leadership subject to corporate governance practices comparable to multinational firms such as AbbVie, Bayer, and Novartis. The company's governance includes audit, compensation, and executive committees modeled similarly to General Electric and subject to oversight by regulatory bodies like the Securities and Exchange Commission. Perrigo's shareholder base has included institutional investors resembling those holding stakes in BlackRock, Vanguard Group, and State Street Corporation, and its governance has at times been influenced by activist investors paralleling episodes at Hertz Global Holdings and Pall Corporation. Cross-border tax planning and domicile choices placed the company amid debates involving rules revised by the U.S. Internal Revenue Service and legislation considered by the United States Congress.

Products and Brands

Perrigo manufactures a wide range of over-the-counter products including analgesics, cough remedies, dermatological preparations, and infant formulas, competing with consumer health portfolios of Reckitt Benckiser, Bayer, and Johnson & Johnson. The company supplies private-label merchandise to major retailers including Walmart, Target Corporation, and Aldi, and its branded lines have sat alongside products from Boots and CVS Pharmacy. Perrigo's product categories overlap with those produced by firms such as Abbott Laboratories in infant nutrition and GlaxoSmithKline Consumer Healthcare in cough and cold remedies. The firm also produces generic prescription pharmaceuticals akin to offerings from Teva Pharmaceutical Industries and Mylan.

Financial Performance and Operations

Perrigo's financial profile has been shaped by revenue from private-label sales, margins affected by raw material costs similar to issues faced by Pfizer and Merck & Co., and impacts from currency fluctuations in markets including the United Kingdom and European Union. The company's earnings announcements and annual reports have been scrutinized by analysts at firms like Goldman Sachs, J.P. Morgan, and Morgan Stanley. Perrigo has managed manufacturing footprints and supply chains with facilities comparable to operations run by Baxter International and distribution networks paralleling McKesson Corporation logistics, with operational adjustments in response to trade policy changes tied to entities such as World Trade Organization rulings and tariffs debated within the United States Congress.

Research, Development, and Regulatory Affairs

Perrigo conducts product formulation and quality control activities integrating standards referenced by regulatory agencies including the U.S. Food and Drug Administration, the European Medicines Agency, and health authorities in countries such as Ireland and Israel. Its R&D focuses on formulation science, manufacturing processes, and compliance with regulatory frameworks similar to processes at Sanofi and Roche. Perrigo's regulatory submissions and manufacturing inspections have involved interactions with inspectors and procedures comparable to those managed by Eli Lilly and Company and have had to address quality concerns in line with industry-wide expectations from organizations like the World Health Organization.

Controversies and Legal Issues

Perrigo's strategic decisions have provoked controversies related to tax inversion proposals and corporate domicile practices that generated debate in the United States Congress and media scrutiny similar to controversy around inversions by Medtronic and Pfizer. The company has faced litigation and regulatory inquiries over product labeling, pricing, and marketing that mirror disputes involving Mallinckrodt and Valeant Pharmaceuticals International. Antitrust and competition scrutiny has arisen in the context of acquisitions, invoking processes reminiscent of reviews by the Federal Trade Commission and the European Commission. Perrigo has also settled or contested legal claims in courts such as federal district courts and arbitration forums, where outcomes have been compared to rulings affecting companies like Allergan and Takeda Pharmaceutical Company.

Category:Pharmaceutical companies